Mobile menu

Bill on Gluten in Medications Reintroduced in Congress

September 30, 2015

Bill on Gluten in Medications Reintroduced in Congress

U.S. Representatives Tim Ryan (OH-13 and Nita Lowey (NY-17) reintroduce the 2013 Gluten in Medicine Disclosure Act in the 114th Congress.

Along with other celiac disease organizations, the National Foundation for Celiac Awareness (NFCA) has long called for gluten to be called out on medication labels or, preferably, completely removed from medications.

In 2013, Ohio Representative Tim Ryan introduced the 2013 Gluten in Medicine Disclosure Act, which would mandate that gluten be disclosed as an ingredient on all medication labels. Congressman Ryan and New York Congresswoman Nita Lowey have reintroduced the bill in the 114th Congress as the Gluten in Medicine Disclosure Act of 2015. The legislation contains the same language as the bill introduced to the 113th Congress. NFCA will continue to support this important bill.

Alice Bast, President and CEO of NFCA applauds the legislation. “From our own FDA-funded research, we know that our celiac disease community is deeply troubled by not having any clear guidance or reassurance that their medications for other ailments don’t in fact, contain gluten. There is a strong fear that a medication that should be treating one condition is actually making them sick and putting them at risk for long term health consequences due to gluten exposure.”

For more information, read these Q&As from 2013 with Congressman Ryan and Congresswoman Lowey.

NFCA will keep you updated on any news surrounding this bill. To learn more about gluten in medications and NFCA’s involvement, visit

Think you may have celiac disease?

Symptoms Checklist